Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance

Abstract Background Inflammatory cytokines have been demonstrated to be involved in developing insulin resistance and type-2 diabetes (T2D). Natural antibodies in the circulation have protective effects on common diseases in humans. The present study was thus designed to test the hypothesis that nat...

Full description

Bibliographic Details
Main Authors: Weiyi Cai, Cailing Qiu, Hongyu Zhang, Xiangyun Chen, Xuan Zhang, Qingyong Meng, Jun Wei
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Journal of Inflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12950-017-0171-6
id doaj-bfcce0e38eea42deb6617b55de3defbb
record_format Article
spelling doaj-bfcce0e38eea42deb6617b55de3defbb2020-11-25T00:29:48ZengBMCJournal of Inflammation1476-92552017-11-011411610.1186/s12950-017-0171-6Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significanceWeiyi Cai0Cailing Qiu1Hongyu Zhang2Xiangyun Chen3Xuan Zhang4Qingyong Meng5Jun Wei6Laboratory for Nursing Science & Institute of Laboratory Medicine, Guangdong Medical UniversityDalang Hospital of DongguanThe Second Hospital, Jilin UniversityDalang Hospital of DongguanThe Second Hospital, Jilin UniversityLaboratory for Nursing Science & Institute of Laboratory Medicine, Guangdong Medical UniversityDivision of Health Research, University of the Highlands & Islands, Centre for Health ScienceAbstract Background Inflammatory cytokines have been demonstrated to be involved in developing insulin resistance and type-2 diabetes (T2D). Natural antibodies in the circulation have protective effects on common diseases in humans. The present study was thus designed to test the hypothesis that natural antibodies against inflammatory cytokines could be associated with T2D. Methods An enzyme-linked immunosorbent assay (ELISA) was developed in-house to detect plasma IgG against peptide antigens derived from interleukin 1α (IL1α), IL1β, IL6, IL8 and tumor necrosis factor-α (TNF-α) in 200 patients with T2D and 220 control subjects. Results Binary regression showed that compared with control subjects, T2D patients had a decreased level of plasma anti-IL6 IgG (adjusted r 2=0.034, p=0.0001), anti-IL8 IgG (adjusted r 2=0.021, p=0.002) and anti-TNF-α IgG (adjusted r 2=0.017, p=0.003). Female patients mainly contributed to decreased levels of anti-IL6 IgG (adjusted r 2=0.065, p=0.0008) and anti-IL8 IgG (adjusted r 2=0.056, p=0.003), while male patients mainly contributed to decreased anti-TNF-α IgG levels (adjusted r 2=0.024, p=0.005). ROC curve analysis revealed a sensitivity of 16.5% against specificity of 95.5% for anti-IL6 IgG assay and a sensitivity of 19.5% against specificity of 95.9% for anti-IL8 IgG assay. Glycated hemoglobin levels measured after 6-month glucose-lowering treatment appeared to be inversely correlated with plasma anti-IL1α IgG (r=-0.477, df=17, p=0.039) and anti-IL6 IgG (r=-0.519, df=17, p=0.023) although such correlation failed to survive the Bonferroni correction. Conclusions Deficiency of natural IgG against inflammatory cytokines is likely to be a risk factor for T2D development and detection of such antibodies may be useful for personalized treatment of the disease.http://link.springer.com/article/10.1186/s12950-017-0171-6Natural antibodiesIgG antibodyInflammatory cytokinesType-2 diabetesELISA
collection DOAJ
language English
format Article
sources DOAJ
author Weiyi Cai
Cailing Qiu
Hongyu Zhang
Xiangyun Chen
Xuan Zhang
Qingyong Meng
Jun Wei
spellingShingle Weiyi Cai
Cailing Qiu
Hongyu Zhang
Xiangyun Chen
Xuan Zhang
Qingyong Meng
Jun Wei
Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
Journal of Inflammation
Natural antibodies
IgG antibody
Inflammatory cytokines
Type-2 diabetes
ELISA
author_facet Weiyi Cai
Cailing Qiu
Hongyu Zhang
Xiangyun Chen
Xuan Zhang
Qingyong Meng
Jun Wei
author_sort Weiyi Cai
title Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
title_short Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
title_full Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
title_fullStr Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
title_full_unstemmed Detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
title_sort detection of circulating natural antibodies to inflammatory cytokines in type-2 diabetes and clinical significance
publisher BMC
series Journal of Inflammation
issn 1476-9255
publishDate 2017-11-01
description Abstract Background Inflammatory cytokines have been demonstrated to be involved in developing insulin resistance and type-2 diabetes (T2D). Natural antibodies in the circulation have protective effects on common diseases in humans. The present study was thus designed to test the hypothesis that natural antibodies against inflammatory cytokines could be associated with T2D. Methods An enzyme-linked immunosorbent assay (ELISA) was developed in-house to detect plasma IgG against peptide antigens derived from interleukin 1α (IL1α), IL1β, IL6, IL8 and tumor necrosis factor-α (TNF-α) in 200 patients with T2D and 220 control subjects. Results Binary regression showed that compared with control subjects, T2D patients had a decreased level of plasma anti-IL6 IgG (adjusted r 2=0.034, p=0.0001), anti-IL8 IgG (adjusted r 2=0.021, p=0.002) and anti-TNF-α IgG (adjusted r 2=0.017, p=0.003). Female patients mainly contributed to decreased levels of anti-IL6 IgG (adjusted r 2=0.065, p=0.0008) and anti-IL8 IgG (adjusted r 2=0.056, p=0.003), while male patients mainly contributed to decreased anti-TNF-α IgG levels (adjusted r 2=0.024, p=0.005). ROC curve analysis revealed a sensitivity of 16.5% against specificity of 95.5% for anti-IL6 IgG assay and a sensitivity of 19.5% against specificity of 95.9% for anti-IL8 IgG assay. Glycated hemoglobin levels measured after 6-month glucose-lowering treatment appeared to be inversely correlated with plasma anti-IL1α IgG (r=-0.477, df=17, p=0.039) and anti-IL6 IgG (r=-0.519, df=17, p=0.023) although such correlation failed to survive the Bonferroni correction. Conclusions Deficiency of natural IgG against inflammatory cytokines is likely to be a risk factor for T2D development and detection of such antibodies may be useful for personalized treatment of the disease.
topic Natural antibodies
IgG antibody
Inflammatory cytokines
Type-2 diabetes
ELISA
url http://link.springer.com/article/10.1186/s12950-017-0171-6
work_keys_str_mv AT weiyicai detectionofcirculatingnaturalantibodiestoinflammatorycytokinesintype2diabetesandclinicalsignificance
AT cailingqiu detectionofcirculatingnaturalantibodiestoinflammatorycytokinesintype2diabetesandclinicalsignificance
AT hongyuzhang detectionofcirculatingnaturalantibodiestoinflammatorycytokinesintype2diabetesandclinicalsignificance
AT xiangyunchen detectionofcirculatingnaturalantibodiestoinflammatorycytokinesintype2diabetesandclinicalsignificance
AT xuanzhang detectionofcirculatingnaturalantibodiestoinflammatorycytokinesintype2diabetesandclinicalsignificance
AT qingyongmeng detectionofcirculatingnaturalantibodiestoinflammatorycytokinesintype2diabetesandclinicalsignificance
AT junwei detectionofcirculatingnaturalantibodiestoinflammatorycytokinesintype2diabetesandclinicalsignificance
_version_ 1725329848951373824